About this item:

60 Views | 36 Downloads

Author Notes:

Jeroen J. Bax, MD PhD, Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands, Postal zone 2300 RC, Phone: +31 71 526 2020, Fax: +31 71 526 6809, j.j.bax@lumc.nl

See publication for full list of authors.

We thank Mohit Pandey M.S. for creating the online score calculator.

Alexander R. van Rosendael is supported by a research grant from the Netherlands Heart Institute (Utrecht, The Netherlands). Arthur J. Scholte received consulting fees from Toshiba Medical Systems and GE Healthcare. The Department of Cardiology of the LUMC received research grants from Biotronik, Medtronic, Boston Scientific Corporation and Edwards Lifesciences.

Subjects:

Research Funding:

The research reported in this publication was funded, in part, by the National Institute of Health (Bethesda, MD, USA) under award number R01 HL115150, and also supported, in part, by the Dalio Institute of Cardiovascular Imaging (New York, NY, USA) and the Michael Wolk Foundation (New York, NY, USA).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Cardiac & Cardiovascular Systems
  • Radiology, Nuclear Medicine & Medical Imaging
  • Cardiovascular System & Cardiology
  • coronary computed tomography angiography
  • risk stratification
  • stable coronary artery disease
  • PROGNOSTIC VALUE
  • ARTERY-DISEASE
  • CLINICAL-OUTCOMES
  • CAUSE MORTALITY
  • DIAGNOSTIC-ACCURACY
  • PREDICTION
  • REGISTRY
  • THERAPY

Superior Risk Stratification With Coronary Computed Tomography Angiography Using a Comprehensive Atherosclerotic Risk Score

Tools:

Journal Title:

JACC-CARDIOVASCULAR IMAGING

Volume:

Volume 12, Number 10

Publisher:

, Pages 1987-1997

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Objectives: This study was designed to assess the prognostic value of a new comprehensive coronary computed tomography angiography (CTA) score compared with the stenosis severity component of the Coronary Artery Disease-Reporting and Data System (CAD-RADS). Background: Current risk assessment with coronary CTA is mainly focused on maximal stenosis severity. Integration of plaque extent, location, and composition in a comprehensive model may improve risk stratification. Methods: A total of 2,134 patients with suspected but without known CAD were included. The predictive value of the comprehensive CTA score (ranging from 0 to 42 and divided into 3 groups: 0 to 5, 6 to 20, and >20) was compared with the CAD-RADS combined into 3 groups (0% to 30%, 30% to 70% and ≥70% stenosis). Its predictive performance was internally and externally validated (using the 5-year follow-up dataset of the CONFIRM [Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry], n = 1,971). Results: The mean age of patients was 55 ± 13 years, mean follow-up 3.6 ± 2.8 years, and 130 events (myocardial infarction or death) occurred. The new, comprehensive CTA score showed strong and independent predictive value using the Cox proportional hazard analysis. A model including clinical variables plus comprehensive CTA score showed better discrimination of events compared with a model consisting of clinical variables plus CAD-RADS (0.768 vs. 0.742, p = 0.001). Also, the comprehensive CTA score correctly reclassified a significant proportion of patients compared with the CAD-RADS (net reclassification improvement 12.4%, p < 0.001). Good predictive accuracy was reproduced in the external validation cohort. Conclusions: The new comprehensive CTA score provides better discrimination and reclassification of events compared with the CAD-RADS score based on stenosis severity only. The score retained similar prognostic accuracy when externally validated. Anatomic risk scores can be improved with the addition of extent, location, and compositional measures of atherosclerotic plaque. (Comprehensive CTA risk score calculator is available at: http://18.224.14.19/calcApp/)

Copyright information:

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Export to EndNote